NeoGenomics, Inc.
$18.94
$0.05 (+0.26%)
$18.77Day Range$19.38
Key Statistics
Market Cap
$2.43B
Shares Outstanding
128.5M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jan 25, 1996
Round Lot
100
Locale
US
Trading Data
Day Open
$18.84
Day High
$19.38
Day Low
$18.77
Volume
1.62M
VWAP
$19.04
Prev Close
$18.89
Transactions
--
Acc. Volume
--
About NeoGenomics, Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
SERVICES-TESTING LABORATORIESSIC 87342,500 employees9490 NEOGENOMICS WAY, FORT MYERS, FL, 33912(239) 768-0600IPO Jan 25, 1996US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001077183
- Composite FIGI
- BBG000BKH263
- Share Class FIGI
- BBG001S9DSY4
- Ticker Root
- NEO
- SIC Code
- 8734
About NeoGenomics, Inc. (NEO) Stock
NeoGenomics, Inc. (NEO) closed the 2026-09-16 session at $18.94, up 0.26% versus the previous close (+0.05). The stock opened at $18.84 and traded between $18.77 and $19.38 during that session. Session trading volume was 1.6M shares. The volume-weighted average price (VWAP) is $19.04.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
NeoGenomics, Inc. has a market capitalization of $2.43 billion. The company operates in the SERVICES-TESTING LABORATORIES industry classification. NEO is listed on the XNAS exchange. The company employs approximately 2,500 people. NeoGenomics, Inc. is headquartered in FORT MYERS, FL. The recorded listing date is 1996-01-25.
On this page you can find market NEO stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SERVICES-TESTING LABORATORIES sector.